Akers Biosciences Inc AKER Balance Sheet

Income Statement

Quarter End	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	17.54M	28.41M	25.25M	21.83M	17.86M	14.49M	26.38M	24.04M
Total Current Assets	5.4M	16.29M	13.14M	9.74M	5.82M	2.46M	14.36M	12.03M
Cash and Equivalents	749k	189k	94k	298k	2.68M	226k	536k	1.19M
Total Non-Current Assets	12.14M	12.12M	12.11M	12.09M	12.05M	12.03M	12.03M	12.02M
Total Liabilities	2.85M	14.4M	13.75M	5.72M	5.09M	4.25M	26M	6.99M
Total Current Liabilities	2.77M	1.63M	2.43M	5.7M	4.99M	3.97M	5.78M	6.99M
Total Non-Current Liabilities	76k	12.78M	11.32M	20k	100k	280k	20.22M	0
Common Equity	108.45M	108.52M	110.71M	112.59M	147k	147k	147k	147k
Retained Earnings	-93.76M	-95.43M	-99.97M	-97.09M	-101.98M	-112.98M	-123.32M	-126M

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	5.09M	10.89M	7.81M	10.89M	36.84M	24.81M	17.54M	17.86M
Total Current Assets	3.19M	9.32M	6.67M	10.31M	36.84M	12.67M	5.4M	5.82M
Cash and Equivalents	73k	438k	182k	517k	18.62M	556k	749k	2.68M
Total Non-Current Assets	3.39M	9.11M	5.83M	9.36M	34.58M	23.65M	14.7M	12.37M
Total Liabilities	1.7M	1.77M	1.97M	1.53M	2.26M	1.17M	2.85M	5.09M
Total Current Liabilities	1.7M	1.77M	1.97M	1.53M	2.26M	1.04M	2.77M	4.99M
Total Non-Current Liabilities	0	0	0	0	0	156k	76k	100k
Total Equity	3.39M	9.11M	5.83M	9.36M	34.58M	23.65M	14.7M	12.37M
Common Equity	100.89M	112.4M	121.56M	128.92M	171.74M	102.21M	108.45M	147k
Retained Earnings	-97.48M	-103.29M	-115.7M	-119.58M	-137.16M	-78.56M	-93.76M	-101.98M